| Application no. and date | 21727630.2 (espacenet) (Federated) (European Patent Register), 20210427 | | Patent/reg. no. and date | DK/EP 4142734, 20250820 | | Publication date | 20230308 | | Priority no. and date | US 202063016886 P, 20200428 | | EP pub. no. and date |
EP 4142734 20230308 | | Effective date | | | Applicant/owner | Oyster Point Pharma, Inc., 202 Carnegie Center, Suite 109
Princeton, New Jersey 08540, US | | Applicant ref. no. | | | Inventor | NAU, Jeffrey Alan,
Princeton, New Jersey 08540, US,
CARLSON, Eric C,
Burleson, Texas 76028, US | | Representative | | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 31/55 (2006.01) , A61K 33/34 (2006.01) , A61K 9/00 (2006.01) , A61P 31/14 (2006.01) | | Title | LOCAL ADMINISTRATION OF NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS FOR THE INHIBITION OF CORONAVIRUS INFECTIONS | | Int. application no. | US2021029375 | | Int. publication no. | WO2021222230 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
